54 results on '"Hatton, Matthew"'
Search Results
2. Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function
3. Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre
4. Retrospective review of patients receiving thoracic palliative radiotherapy (TRT) for non-small-cell lung cancer (NSCLC) in Weston Park Cancer Centre (WPCC): a real world regional cancer centre experience
5. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC
6. Thoracic umbrella radiotherapy study in stage IV NSCLC: TOURIST
7. Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel
8. Embedding qualitative research in lung cancer trials: Thoracic Umbrella Radiotherapy Study in stage IV NSCLC: TOURIST
9. Analyses of real-world data on patient outcomes in South Yorkshire, for patients with metastatic non-squamous lung cancer treated with pembrolizumab plus pemetrexed-platinum-based chemotherapy
10. Unaccounted Confounders Limit the Ability to Draw Conclusions From Big Data Analysis Comparing Radiotherapy Fractionation Regimens in NSCLC
11. The impact of cardiac dose on overall survival of thoracic oncology patients following radiotherapy: a systematic review
12. Analysis of clinical outcomes of extensive stage small-cell lung cancer patients treated with atezolizumab at Weston Park Hospital
13. Postoperative Radiation Therapy Should Not Be Used for the Therapy of Stage III-N2 NSCLC
14. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial
15. Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality
16. Retrospective study to compare the dosimetric difference on treatment volume (PTV) and lung V20 in patients receiving lung stereotactic ablative radiotherapy (SABR) based on use of abdominal compression
17. Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
18. Real-world-outcomes for ALK positive advanced NSCLC patients treated in South Yorkshire
19. Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer
20. Stereotactic radiotherapy and oligometastases – Authors' reply
21. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
22. Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer
23. Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study
24. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
25. Post-Operative Radiotherapy (PORT) Versus No PORT in Patients With Completely Resected Non-Small Cell Lung Cancer and Proven Mediastinal N2 Involvement: An Open Label Randomised Phase 3 Superiority Trial (Lung ART (IFCT-0503, UK NCRI, SAKK))
26. Radical accelerated radiotherapy for non-small cell lung cancer (NSCLC): A 5-year retrospective review of two dose fractionation schedules
27. The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy
28. Spatial Comparison of CT-Based Surrogates of Lung Ventilation With Hyperpolarized Helium-3 and Xenon-129 Gas MRI in Patients Undergoing Radiation Therapy
29. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
30. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial
31. Sequential chemotherapy plus continuous hyper-fractionated accelerated radiation therapy
32. P2.05-041 Accelerated Radical Radiotherapy for Non Small Cell Lung Cancer: Single Centre Experience of Two Fractionations
33. P2.05-032 CT-Based Surrogates of Pulmonary Ventilation in Lung Cancer: A Voxel-Level Comparison with HP Gas MRI
34. P2.05-045 Accelerated Radical Radiotherapy for Non-Small Cell Lung Cancer: Single Centre Experience of Two Schedules in the Treatment of Elderly Patients
35. Continuous hyperfractionated accelerated radiotherapy – Escalated dose (CHART-ED): A phase I study
36. Radiotherapy for extensive stage small-cell lung cancer – Authors' reply
37. Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres
38. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
39. Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer
40. Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer: The MRC INCH Randomized Trial
41. Detection of radiation-induced lung injury in non-small cell lung cancer patients using hyperpolarized helium-3 magnetic resonance imaging
42. Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study
43. Routine Use of Continuous, Hyperfractionated, Accelerated Radiotherapy for Non–Small-Cell Lung Cancer: A Five-Center Experience
44. P1-066: Image acquisition protocol to optimize image registration of lung cancer hyperpolarized helium-3 MRI and CT
45. D1-01: Prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer (ED-SCLC) after response to chemotherapy (EORTC 08993-22993): Quality of life (QoL) results.
46. PRS-04: A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC)
47. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
48. Feasibility of Image Registration and Intensity-Modulated Radiotherapy Planning With Hyperpolarized Helium-3 Magnetic Resonance Imaging for Non–Small-Cell Lung Cancer
49. P-241 Pulmonary resection after neoadjuvant chemotherapy increases the use of resources with acceptable outcomes
50. P-94 Early results from a single UK multi-disciplinary lung cancer team
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.